A Risk Sciences International news item posted on June 29, 2016 and last updated on September 3, 2019

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs for psoriasis, a common skin disorder affecting an estimated 7.5 million people. While corticosteroid and other topical drugs are sufficient for many cases, potent immunosuppressant drugs are used in increasing numbers. This report also provides new evidence that drugs for erectile dysfunction and pulmonary arterial hypertension can cause deafness or sudden hearing loss.

More RSI News

RSI launches game-changing climate app

June 30, 2016

RSI launched the Climate Change Hazards Information Portal (CCHIP).

Climate change modelling for the Bow River watershed

June 29, 2016

Following up on the recommendations put forth by the Expert Management Panel on River Flood Mitigation, the Environmental and Safety Management (ESM) and Water Resources (WS)…

Climate change modelling for the Bow River watershed

June 29, 2016

Developing a suite of watershed-scale climate models.

QuarterWatch analyzes MedWatch Reports

June 29, 2016

This issue of QuarterWatch analyzes MedWatch Reports from the third quarter of 2015. This issue identifies major differences in reports of cancer associated with drugs…